DSM considers stake sale in chemicals and pharma JVs, could net EUR 1.5bn-EUR 2.5bn
DSM (AMS:DSM), the Dutch biotech and chemicals company, could sell its stake in three chemicals and pharma JVs signed last year.
Dutch-language De Telegraaf reported this information in an article about the company's quarterly results, citing CEO Feike Sijbesma. The stake sale could fetch the company between EUR 1.5bn and EUR 2.5bn, it added.
Sijbesma reiterated DSM intends to sell its remaining stake in these JVs, the item noted.
The company does not expect further changes in its portfolio until 2018, Sijbesma said.
DSM's EBITDA of EUR 296m for 1Q16 beat market expectations, the item noted.
de Telegraaf